Semler Scientific Hits New 52-Week Low at $18.45 Amid Ongoing Struggles

Semler Scientific, Inc., a microcap company in the Pharmaceuticals & Biotechnology sector, has reached a new 52-week low of USD 18.45 on November 20, 2025. This significant decline reflects a challenging year for the company, which has seen its stock price drop by 49.09% over the past year, contrasting sharply with the S&P 500's performance of 12.26% during the same period. The company has faced difficulties, reporting negative results for the last four consecutive quarters, including a notable downturn in June 2024 after a streak of six negative quarters. Key financial metrics indicate a struggling operational performance, with the lowest operating cash flow recorded at USD 12.45 million and net sales at USD 8.22 million. Additionally, the return on equity stands at 3.43%, and the price-to-book ratio is 1.11. Semler Scientific's market capitalization is currently USD 425 million, and it has not offered any dividends, reflecting its focus on navigating through these financial challenges. The stock's previous 52-week high was USD 81.56, highlighting the extent of its recent decline.